Silicon Laboratories Inc. (FRA:LA5)
Germany · Delayed Price · Currency is EUR 115.00
-1.00 (-0.86%)
At close: Jan 28, 2026
Silicon Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 4, 2025 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 2, 2021 |
| 742.81 | 584.39 | 782.26 | 1,024 | 720.86 | 510.93 | |
Revenue Growth (YoY) | 47.10% | -25.30% | -23.62% | 42.07% | 41.09% | 7.84% |
Cost of Revenue | 327.68 | 272.2 | 321.67 | 381.55 | 295.47 | 216.08 |
Gross Profit | 415.13 | 312.19 | 460.59 | 642.56 | 425.39 | 294.85 |
Selling, General & Admin | 164.88 | 145.45 | 147 | 190.97 | 185.02 | 166.75 |
Research & Development | 346.16 | 332.23 | 337.74 | 332.33 | 273.21 | 235.19 |
Operating Expenses | 511.04 | 477.68 | 484.74 | 523.3 | 458.23 | 401.93 |
Operating Income | -95.92 | -165.49 | -24.15 | 119.26 | -32.84 | -107.09 |
Interest Expense | -1.02 | -1.31 | -5.55 | -6.72 | -31.03 | -34.14 |
Interest & Investment Income | 13.65 | 11.99 | 19.17 | 13.92 | 5.7 | 8.52 |
Earnings From Equity Investments | - | - | -16.03 | 3.4 | 13.73 | 2.12 |
EBT Excluding Unusual Items | -83.29 | -154.81 | -26.57 | 129.85 | -44.45 | -130.6 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.51 |
Pretax Income | -83.29 | -154.81 | -26.57 | 129.85 | -44.45 | -130.09 |
Income Tax Expense | 2.76 | 36.2 | 7.94 | 38.45 | 13.43 | -14.6 |
Earnings From Continuing Operations | -86.05 | -191.01 | -34.52 | 91.4 | -57.87 | -115.49 |
Earnings From Discontinued Operations | - | - | - | - | 2,175 | 128.02 |
Net Income | -86.05 | -191.01 | -34.52 | 91.4 | 2,117 | 12.53 |
Net Income to Common | -86.05 | -191.01 | -34.52 | 91.4 | 2,117 | 12.53 |
Net Income Growth | - | - | - | -95.68% | 16797.29% | -34.96% |
Shares Outstanding (Basic) | 33 | 32 | 32 | 35 | 43 | 44 |
Shares Outstanding (Diluted) | 33 | 32 | 32 | 36 | 44 | 44 |
Shares Change (YoY) | 1.71% | 1.22% | -11.76% | -18.67% | 1.23% | 0.99% |
EPS (Basic) | -2.64 | -5.93 | -1.09 | 2.61 | 49.44 | 0.29 |
EPS (Diluted) | -2.64 | -5.93 | -1.09 | 2.54 | 49.44 | 0.28 |
EPS Growth | - | - | - | -94.86% | 17282.52% | -35.83% |
Free Cash Flow | 73.58 | -25.66 | -52.63 | 45.28 | -129.02 | 117.63 |
Free Cash Flow Per Share | 2.26 | -0.80 | -1.66 | 1.26 | -2.91 | 2.69 |
Gross Margin | 55.89% | 53.42% | 58.88% | 62.74% | 59.01% | 57.71% |
Operating Margin | -12.91% | -28.32% | -3.09% | 11.64% | -4.55% | -20.96% |
Profit Margin | -11.58% | -32.69% | -4.41% | 8.92% | 293.73% | 2.45% |
Free Cash Flow Margin | 9.91% | -4.39% | -6.73% | 4.42% | -17.90% | 23.02% |
EBITDA | -54.39 | -116.91 | 26.93 | 175.86 | 29.72 | -48.25 |
EBITDA Margin | -7.32% | -20.00% | 3.44% | 17.17% | 4.12% | -9.44% |
D&A For EBITDA | 41.53 | 48.59 | 51.08 | 56.6 | 62.56 | 58.84 |
EBIT | -95.92 | -165.49 | -24.15 | 119.26 | -32.84 | -107.09 |
EBIT Margin | -12.91% | -28.32% | -3.09% | 11.64% | -4.55% | -20.96% |
Effective Tax Rate | - | - | - | 29.61% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.